HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intracardiac metastases of primary neuroectodermal tumor].

AbstractBACKGROUND:
Cardiac metastases from malignant tumors are rare in children and are usually found only at necropsy.
CASE REPORT:
A girl aged 6 months developed a swelling in the area of her left shoulder. Surgical excision was incomplete and pathological examination indicated neuroectodermic soft-tissue tumor. Chemotherapy with cyclophosphamide, doxorubicin then vincristine and actinomycin D was instituted, followed by second course of cyclophosphamide-doxorubicin. Three months after cessation of chemotherapy, the child developed manifestations of congestive cardiac failure that could not be induced by anthracycline (total cumulative dose: 275 mg/m2). Cardiac ultrasonography showed a metastatic tumor (diam = 3 cm) on the wall of the right ventricle and atrium, which was pedunculated inside the infundibular chamber. It was partly excised, and the patient was treated with etoposide and carboplatin. But a second metastatic tumor formed in the paravertebral area.
CONCLUSION:
This is the first description, to our knowledge, of cardiac metastases from neuroectodermic tumor. They were diagnosed by cardiac ultrasonography, as this imaging technique differentiates this complication from the anthracycline-induced cardiomyopathy usually seen in children developing cardiac failure under chemotherapy.
AuthorsF Millot, M Lefèvre, D Blanchard, J C Roze, D Duveau, J L Harousseau
JournalArchives francaises de pediatrie (Arch Fr Pediatr) Vol. 49 Issue 5 Pg. 449-50 (May 1992) ISSN: 0003-9764 [Print] France
Vernacular TitleMétastases intracardiaques d'une tumeur neuroectodermique primitive.
PMID1326935 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Female
  • Heart Neoplasms (diagnosis, secondary, surgery)
  • Humans
  • Infant
  • Neoplasms, Nerve Tissue
  • Soft Tissue Neoplasms

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: